{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:27:17Z","timestamp":1769232437945,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,28]],"date-time":"2011-02-28T00:00:00Z","timestamp":1298851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1756-0500-4-42","type":"journal-article","created":{"date-parts":[[2011,3,2]],"date-time":"2011-03-02T00:02:24Z","timestamp":1299024144000},"source":"Crossref","is-referenced-by-count":16,"title":["Prevalence of invasive fungal disease in hematological patients at a tertiary university hospital in Singapore"],"prefix":"10.1186","volume":"4","author":[{"given":"Siok-Ying","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chay-Leng","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winnie H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L","family":"Kwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Piu","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Yang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,28]]},"reference":[{"key":"795_CR1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1445-5994.2008.01723.x","volume":"38","author":"MA Slavin","year":"2008","unstructured":"Slavin MA, Heath CH, Thursky KA, Morrissey CO, Szer J, Ling LM, Milliken ST, Grigg AP: Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy. Internal Medicine Journal. 2008, 38: 468-476. 10.1111\/j.1445-5994.2008.01723.x.","journal-title":"Internal Medicine Journal"},{"key":"795_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1086\/649879","volume":"50","author":"K Leventakos","year":"2010","unstructured":"Leventakos K, Lewis RE, Kontoyiannis DP: Fungal infections in leukemia patients: how do we prevent and treat them?. Clin Infect Dis. 2010, 50: 405-15. 10.1086\/649879.","journal-title":"Clin Infect Dis"},{"key":"795_CR3","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1200\/JCO.2007.12.3851","volume":"25","author":"E Robenshtok","year":"2007","unstructured":"Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, Leibovici L, Paul M: Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol. 2007, 25: 5471-89. 10.1200\/JCO.2007.12.3851.","journal-title":"J Clin Oncol"},{"key":"795_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG: Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010, 50: 1091-100. 10.1086\/651263.","journal-title":"Clin Infect Dis"},{"key":"795_CR5","first-page":"1068","volume":"91","author":"L Pagano","year":"2006","unstructured":"Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, Pastore D, Picardi M, Bonini A, Chierichini A, Fanci R, Caramatti C, Invernizzi R, Mattei D, Mitra ME, Melillo L, Aversa F, Van Lint MT, Falcucci P, Valentini CG, Girmenia C, Nosari A: The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006, 91: 1068-75.","journal-title":"Haematologica"},{"key":"795_CR6","unstructured":"Noxafil (posaconazole) oral suspension [package insert]. 2006, Kenilworth, NJ: Schering Corp"},{"key":"795_CR7","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TH, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Mu\u00f1oz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infections Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008, 46: 1813-21. 10.1086\/588660.","journal-title":"Clin Infect Dis"},{"key":"795_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2334-10-44","volume":"10","author":"LY Hsu","year":"2010","unstructured":"Hsu LY, Ding Y, Phua J, Koh LP, Chan DS, Khoo KL, Tambyah PA: Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients. BMC Infect Dis. 2010, 10: 44-10.1186\/1471-2334-10-44.","journal-title":"BMC Infect Dis"},{"key":"795_CR9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1128\/JCM.43.2.662-668.2005","volume":"43","author":"M Kumar","year":"2005","unstructured":"Kumar M, Shukla PK: Use of PCR targeting internal transcribed spacer regions and single-stranded conformation polymorphism analysis of sequence variation in different regions of rrna genes in fungi for rapid diagnosis of mycotic keratitis. J Clin Microbiol. 2005, 43: 662-8. 10.1128\/JCM.43.2.662-668.2005.","journal-title":"J Clin Microbiol"},{"key":"795_CR10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1056\/NEJMoa061094","volume":"356","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D: Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with neutropenia. New Eng J Med. 2007, 356: 348-59. 10.1056\/NEJMoa061094.","journal-title":"New Eng J Med"},{"key":"795_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"AJ Ullmann","year":"2007","unstructured":"Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, Greinex H, Morais de Azevedo W, Reddy V, Boparai N, Pedicone L, Patino H, Durrant S: Posaconazole or fluconazole for prophylaxis of severe graft-versus-host disease. N Engl J Med. 2007, 356: 335-47. 10.1056\/NEJMoa061098.","journal-title":"N Engl J Med"},{"key":"795_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/sj.bmt.1700737","volume":"19","author":"E Jantunen","year":"1997","unstructured":"Jantunen E, Ruutu P, Niskanen L, Volin L, Parkkali T, Koukila-Kahkola P, Ruutu T: Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant. 1997, 19: 801-8. 10.1038\/sj.bmt.1700737.","journal-title":"Bone Marrow Transplant"},{"key":"795_CR13","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/jac\/dkq121","volume":"65","author":"JJ Vehreschild","year":"2010","unstructured":"Vehreschild JJ, R\u00fcping MJ, Wisplinghoff H, Farowski F, Steinbach A, Sims R, Stollorz A, Kreuzer KA, Hallek M, Bangard C, Cornely OA: Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukemia (AML): a 6 year experience of the Cologne AML cohort. J Antimicrob Chemother. 2010, 65: 1466-71. 10.1093\/jac\/dkq121.","journal-title":"J Antimicrob Chemother"},{"key":"795_CR14","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1086\/587177","volume":"46","author":"OA Cornely","year":"2008","unstructured":"Cornely OA, Ullmann AJ: Numbers need to treat with posaconazole prophylaxis to prevent invasive fungal infection and death. Clin Infect Dis. 2008, 46: 1626-7. 10.1086\/587177.","journal-title":"Clin Infect Dis"},{"key":"795_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/bmt.2009.272","volume":"45","author":"R De la Camara","year":"2010","unstructured":"De la Camara R, Jarque I, Sanz MA, Grau S, Casado MA, Sabater FJ, Carreras E: Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT. Bone Marrow Transplant. 2010, 45: 925-32. 10.1038\/bmt.2009.272.","journal-title":"Bone Marrow Transplant"},{"key":"795_CR16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1524-4733.2008.00486.x","volume":"12","author":"AK O'Sullivan","year":"2009","unstructured":"O'Sullivan AK, Pandya A, Papadopoulos G, Thompson D, Langston A, Perfect J, Weinstein MC: Cost-Effectiveness of Posaconazole versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infections among Neutropenic Patients in the United States. Value Health. 2009, 12: 666-73.","journal-title":"Value Health"},{"key":"795_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1600-0609.2008.01141.x","volume":"81","author":"WB Stam","year":"2008","unstructured":"Stam WB, O'Sullivan AK, Rijnders B, Lugtenburg E, Span LF, Janssen JJ, Jansen JP: Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands. Eur J Haematol. 2008, 81: 467-74. 10.1111\/j.1600-0609.2008.01141.x.","journal-title":"Eur J Haematol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-4-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-0500-4-42\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-4-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T20:30:02Z","timestamp":1548102602000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-4-42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,28]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-4-42","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,28]]},"article-number":"42"}}